Genky DrugStores Co., Ltd.
9267.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.39 | 0.41 | 1.81 | -1.36 |
| FCF Yield | -2.15% | 3.33% | -1.73% | -8.68% |
| EV / EBITDA | 8.78 | 7.55 | 8.00 | 7.13 |
| Quality | ||||
| ROIC | 7.50% | 7.98% | 6.19% | 5.92% |
| Gross Margin | 20.36% | 20.35% | 20.44% | 20.02% |
| Cash Conversion Ratio | 1.78 | 2.10 | 1.31 | 1.00 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.90% | 6.13% | 5.89% | 7.75% |
| Free Cash Flow Growth | -188.63% | 343.72% | 73.94% | -242.00% |
| Safety | ||||
| Net Debt / EBITDA | 1.72 | 1.71 | 2.30 | 2.38 |
| Interest Coverage | 44.72 | 87.53 | 95.84 | 96.04 |
| Efficiency | ||||
| Inventory Turnover | 5.91 | 6.13 | 5.98 | 5.91 |
| Cash Conversion Cycle | 14.25 | 13.60 | 14.16 | 12.39 |